Ladenson P W
Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am J Med. 1990 Jun;88(6):638-41. doi: 10.1016/0002-9343(90)90532-i.
Hypothyroidism and hyperthyroidism are both associated with clinically significant cardiovascular derangements. In hypothyroidism, these include pericardial effusion, heart failure, and the complex interrelationship between hypothyroidism and ischemic heart disease. Cardiovascular disorders associated with hyperthyroidism include atrial tachyarrhythmias, mitral valve dysfunction, and heart failure. Although these usually occur in individuals with intrinsic heart disease, thyroid dysfunction alone rarely causes serious but reversible cardiovascular dysfunction. Patients with commonly encountered cardiac disorders, e.g., idiopathic cardiomyopathy and atrial fibrillation, should be screened for potentially contributing subclinical thyroid diseases. In patients with heart failure and hypothyroidism, initial management should focus on diagnosis and optimal management of any primary cardiac disease, whereas in hyperthyroidism, aggressive measures to control excess thyroid hormone action should generally have the highest priority.
甲状腺功能减退症和甲状腺功能亢进症均与具有临床意义的心血管功能紊乱相关。在甲状腺功能减退症中,这些情况包括心包积液、心力衰竭以及甲状腺功能减退症与缺血性心脏病之间复杂的相互关系。与甲状腺功能亢进症相关的心血管疾病包括房性快速心律失常、二尖瓣功能障碍和心力衰竭。虽然这些情况通常发生在患有原发性心脏病的个体中,但单纯的甲状腺功能障碍很少导致严重但可逆的心血管功能障碍。患有常见心脏疾病(如特发性心肌病和心房颤动)的患者应筛查可能存在的亚临床甲状腺疾病。对于心力衰竭合并甲状腺功能减退症的患者,初始治疗应侧重于诊断和对任何原发性心脏病的优化管理,而对于甲状腺功能亢进症患者,积极控制甲状腺激素过量作用的措施通常应列为首要任务。